United States Cell Therapy Market Report 2017

October 2017 | 121 pages | ID: U05CEBBE0BAWEN
QYResearch

Abstracts

In this report, the United States Cell Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Cell Therapy in these regions, from 2012 to 2022 (forecast).

United States Cell Therapy market competition by top manufacturers/players, with Cell Therapy sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Dendreon
• Mesoblast
• Vericel
• AlloCure
• Amorcyte
• Anterogen
• Antibe Therapeutics
• Astellas Pharma
• Athersys
• Avita Medical
• AxoGen
• Bellicum Pharmaceuticals
• BioCardia
• BIOCELLULAR THERAPIES
• Biogen Idec
• Bio-Tissue
• BIOTIME
• BioTissue Technologies
• BrainStorm Cell Therapeutics
• Bluebird Bio
• Bone Therapeutics
• Caladrius
• Capricor Therapeutics
• CellBioMed
• Celgene
• Cell Medica

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Nanotechnology
• Natural Substances

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Cell Therapy for each application, including

• Scientific Research
• Hospital
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Cell Therapy Market Report 2017

1 CELL THERAPY OVERVIEW

1.1 Product Overview and Scope of Cell Therapy
1.2 Classification of Cell Therapy by Product Category
  1.2.1 United States Cell Therapy Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Cell Therapy Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Nanotechnology
  1.2.4 Natural Substances
1.3 United States Cell Therapy Market by Application/End Users
  1.3.1 United States Cell Therapy Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Scientific Research
  1.3.3 Hospital
  1.3.4 Other
1.4 United States Cell Therapy Market by Region
  1.4.1 United States Cell Therapy Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Cell Therapy Status and Prospect (2012-2022)
  1.4.3 Southwest Cell Therapy Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Cell Therapy Status and Prospect (2012-2022)
  1.4.5 New England Cell Therapy Status and Prospect (2012-2022)
  1.4.6 The South Cell Therapy Status and Prospect (2012-2022)
  1.4.7 The Midwest Cell Therapy Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cell Therapy (2012-2022)
  1.5.1 United States Cell Therapy Sales and Growth Rate (2012-2022)
  1.5.2 United States Cell Therapy Revenue and Growth Rate (2012-2022)

2 UNITED STATES CELL THERAPY MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Cell Therapy Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cell Therapy Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cell Therapy Average Price by Players/Suppliers (2012-2017)
2.4 United States Cell Therapy Market Competitive Situation and Trends
  2.4.1 United States Cell Therapy Market Concentration Rate
  2.4.2 United States Cell Therapy Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cell Therapy Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CELL THERAPY SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Cell Therapy Sales and Market Share by Region (2012-2017)
3.2 United States Cell Therapy Revenue and Market Share by Region (2012-2017)
3.3 United States Cell Therapy Price by Region (2012-2017)

4 UNITED STATES CELL THERAPY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Cell Therapy Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cell Therapy Revenue and Market Share by Type (2012-2017)
4.3 United States Cell Therapy Price by Type (2012-2017)
4.4 United States Cell Therapy Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CELL THERAPY SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Cell Therapy Sales and Market Share by Application (2012-2017)
5.2 United States Cell Therapy Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CELL THERAPY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Dendreon
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cell Therapy Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Dendreon Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Mesoblast
  6.2.2 Cell Therapy Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Mesoblast Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Vericel
  6.3.2 Cell Therapy Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Vericel Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 AlloCure
  6.4.2 Cell Therapy Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 AlloCure Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Amorcyte
  6.5.2 Cell Therapy Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Amorcyte Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Anterogen
  6.6.2 Cell Therapy Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Anterogen Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Antibe Therapeutics
  6.7.2 Cell Therapy Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Antibe Therapeutics Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Astellas Pharma
  6.8.2 Cell Therapy Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Astellas Pharma Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Athersys
  6.9.2 Cell Therapy Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Athersys Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Avita Medical
  6.10.2 Cell Therapy Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Avita Medical Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 AxoGen
6.12 Bellicum Pharmaceuticals
6.13 BioCardia
6.14 BIOCELLULAR THERAPIES
6.15 Biogen Idec
6.16 Bio-Tissue
6.17 BIOTIME
6.18 BioTissue Technologies
6.19 BrainStorm Cell Therapeutics
6.20 Bluebird Bio
6.21 Bone Therapeutics
6.22 Caladrius
6.23 Capricor Therapeutics
6.24 CellBioMed
6.25 Celgene
6.26 Cell Medica

7 CELL THERAPY MANUFACTURING COST ANALYSIS

7.1 Cell Therapy Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cell Therapy

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cell Therapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cell Therapy Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CELL THERAPY MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Cell Therapy Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cell Therapy Sales Volume Forecast by Type (2017-2022)
11.3 United States Cell Therapy Sales Volume Forecast by Application (2017-2022)
11.4 United States Cell Therapy Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Cell Therapy
Figure United States Cell Therapy Market Size (K Units) by Type (2012-2022)
Figure United States Cell Therapy Sales Volume Market Share by Type (Product Category) in 2016
Figure Nanotechnology Product Picture
Figure Natural Substances Product Picture
Figure United States Cell Therapy Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Cell Therapy by Application in 2016
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Cell Therapy Market Size (Million USD) by Region (2012-2022)
Figure The West Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cell Therapy Sales (K Units) and Growth Rate (2012-2022)
Figure United States Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cell Therapy Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Cell Therapy Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Cell Therapy Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cell Therapy Sales Share by Players/Suppliers
Figure 2017 United States Cell Therapy Sales Share by Players/Suppliers
Figure United States Cell Therapy Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cell Therapy Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cell Therapy Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cell Therapy Revenue Share by Players/Suppliers
Figure 2017 United States Cell Therapy Revenue Share by Players/Suppliers
Table United States Market Cell Therapy Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Cell Therapy Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Cell Therapy Market Share of Top 3 Players/Suppliers
Figure United States Cell Therapy Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cell Therapy Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cell Therapy Product Category
Table United States Cell Therapy Sales (K Units) by Region (2012-2017)
Table United States Cell Therapy Sales Share by Region (2012-2017)
Figure United States Cell Therapy Sales Share by Region (2012-2017)
Figure United States Cell Therapy Sales Market Share by Region in 2016
Table United States Cell Therapy Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cell Therapy Revenue Share by Region (2012-2017)
Figure United States Cell Therapy Revenue Market Share by Region (2012-2017)
Figure United States Cell Therapy Revenue Market Share by Region in 2016
Table United States Cell Therapy Price (USD/Unit) by Region (2012-2017)
Table United States Cell Therapy Sales (K Units) by Type (2012-2017)
Table United States Cell Therapy Sales Share by Type (2012-2017)
Figure United States Cell Therapy Sales Share by Type (2012-2017)
Figure United States Cell Therapy Sales Market Share by Type in 2016
Table United States Cell Therapy Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cell Therapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cell Therapy by Type (2012-2017)
Figure Revenue Market Share of Cell Therapy by Type in 2016
Table United States Cell Therapy Price (USD/Unit) by Types (2012-2017)
Figure United States Cell Therapy Sales Growth Rate by Type (2012-2017)
Table United States Cell Therapy Sales (K Units) by Application (2012-2017)
Table United States Cell Therapy Sales Market Share by Application (2012-2017)
Figure United States Cell Therapy Sales Market Share by Application (2012-2017)
Figure United States Cell Therapy Sales Market Share by Application in 2016
Table United States Cell Therapy Sales Growth Rate by Application (2012-2017)
Figure United States Cell Therapy Sales Growth Rate by Application (2012-2017)
Table Dendreon Basic Information List
Table Dendreon Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dendreon Cell Therapy Sales Growth Rate (2012-2017)
Figure Dendreon Cell Therapy Sales Market Share in United States (2012-2017)
Figure Dendreon Cell Therapy Revenue Market Share in United States (2012-2017)
Table Mesoblast Basic Information List
Table Mesoblast Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mesoblast Cell Therapy Sales Growth Rate (2012-2017)
Figure Mesoblast Cell Therapy Sales Market Share in United States (2012-2017)
Figure Mesoblast Cell Therapy Revenue Market Share in United States (2012-2017)
Table Vericel Basic Information List
Table Vericel Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Vericel Cell Therapy Sales Growth Rate (2012-2017)
Figure Vericel Cell Therapy Sales Market Share in United States (2012-2017)
Figure Vericel Cell Therapy Revenue Market Share in United States (2012-2017)
Table AlloCure Basic Information List
Table AlloCure Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AlloCure Cell Therapy Sales Growth Rate (2012-2017)
Figure AlloCure Cell Therapy Sales Market Share in United States (2012-2017)
Figure AlloCure Cell Therapy Revenue Market Share in United States (2012-2017)
Table Amorcyte Basic Information List
Table Amorcyte Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amorcyte Cell Therapy Sales Growth Rate (2012-2017)
Figure Amorcyte Cell Therapy Sales Market Share in United States (2012-2017)
Figure Amorcyte Cell Therapy Revenue Market Share in United States (2012-2017)
Table Anterogen Basic Information List
Table Anterogen Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Anterogen Cell Therapy Sales Growth Rate (2012-2017)
Figure Anterogen Cell Therapy Sales Market Share in United States (2012-2017)
Figure Anterogen Cell Therapy Revenue Market Share in United States (2012-2017)
Table Antibe Therapeutics Basic Information List
Table Antibe Therapeutics Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Antibe Therapeutics Cell Therapy Sales Growth Rate (2012-2017)
Figure Antibe Therapeutics Cell Therapy Sales Market Share in United States (2012-2017)
Figure Antibe Therapeutics Cell Therapy Revenue Market Share in United States (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Cell Therapy Sales Growth Rate (2012-2017)
Figure Astellas Pharma Cell Therapy Sales Market Share in United States (2012-2017)
Figure Astellas Pharma Cell Therapy Revenue Market Share in United States (2012-2017)
Table Athersys Basic Information List
Table Athersys Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Athersys Cell Therapy Sales Growth Rate (2012-2017)
Figure Athersys Cell Therapy Sales Market Share in United States (2012-2017)
Figure Athersys Cell Therapy Revenue Market Share in United States (2012-2017)
Table Avita Medical Basic Information List
Table Avita Medical Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Avita Medical Cell Therapy Sales Growth Rate (2012-2017)
Figure Avita Medical Cell Therapy Sales Market Share in United States (2012-2017)
Figure Avita Medical Cell Therapy Revenue Market Share in United States (2012-2017)
Table AxoGen Basic Information List
Table Bellicum Pharmaceuticals Basic Information List
Table BioCardia Basic Information List
Table BIOCELLULAR THERAPIES Basic Information List
Table Biogen Idec Basic Information List
Table Bio-Tissue Basic Information List
Table BIOTIME Basic Information List
Table BioTissue Technologies Basic Information List
Table BrainStorm Cell Therapeutics Basic Information List
Table Bluebird Bio Basic Information List
Table Bone Therapeutics Basic Information List
Table Caladrius Basic Information List
Table Capricor Therapeutics Basic Information List
Table CellBioMed Basic Information List
Table Celgene Basic Information List
Table Cell Medica Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cell Therapy
Figure Manufacturing Process Analysis of Cell Therapy
Figure Cell Therapy Industrial Chain Analysis
Table Raw Materials Sources of Cell Therapy Major Players/Suppliers in 2016
Table Major Buyers of Cell Therapy
Table Distributors/Traders List
Figure United States Cell Therapy Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cell Therapy Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Cell Therapy Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cell Therapy Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cell Therapy Sales Volume (K Units) Forecast by Type in 2022
Table United States Cell Therapy Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cell Therapy Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cell Therapy Sales Volume (K Units) Forecast by Application in 2022
Table United States Cell Therapy Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Cell Therapy Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cell Therapy Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cell Therapy Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources